- Cosumers menu
- About Generation One
- Leadership Team
- Board of Directors
About GenerationOne
GenerationOne was founded by a group of both medical and technical professionals to create a better, more effective way to manage health and wellness. Our vision was to develop the industry’s preeminent mobile engagement platform that delivers next-generation cost containment for the healthcare industry. Using mobile solutions for driving collaborative care represents a paradigm shift from traditional care management.
GenerationOne’s mobile engagement platform empowers individuals to actively manage their health and wellness, so that patients with chronic illness can improve outcomes and healthy individuals can optimize their health status. Our continuous transmission and capture of vital health information transforms care from retroactive, event-based, care management to patient empowerment with real-time detection and prioritized management. The platform can be implemented using patients’ existing phones or GenerationOne provisioned health-optimized mobile phones, and can support unlimited care paths, including chronic care and wellness initiatives.
GenerationOne specializes in delivering technology solutions that help the healthcare industry overcome challenges implementing mobile-based programs. We anticipate the direction and ever evolving needs of the healthcare industry, and our team is committed to innovation and providing our customers with break-through solutions.
Leadership Team:
Nathan Pendleton
Chief Operating Officer
Mr. Pendleton has twenty years experience in sales and operations management in the health care and insurance industries. Prior to joining GenerationOne, Mr. Pendleton held Vice President of Sales roles with UnitedHealth Group divisions, including United Healthcare/Definity Health and Ingenix, and Vice President of Strategic Accounts, Payer Market at OptumHealth. Previous experience also includes sales management of national sales teams at HealthPlan Services (formerly Dun & Bradstreet Plan Services), Lumenos and Insurance Central. For his work at both Lumenos and Definity Health, he is a recognized expert on Consumer Driven Healthcare (CDH was co-invented by the two companies). He still holds several insurance and financial licenses and is an approved continuing education instructor for health insurance in the State of Florida. Mr. Pendleton received a B.S. in Marketing from the University of South Florida.
Don Rosen
Chief Technology Officer
Throughout his career, Mr. Rosen has been responsible for activities supporting healthcare and pharmaceutical industry clients worldwide, combining management consulting and business information systems planning with systems implementation and organizational change management. In addition to his work overseeing GenerationOne’s technology strategy and development, Mr. Rosen is the U.S. Chair of the Drug Information Association (DIA) eClinical Special Interest Area Community (SIAC) and previously co-chaired the Clinical Data Interchange Standards Consortium (CDISC) Industry Advisory Board. He is a member of the Continua Health Alliance and Health Level Seven (HL7). Prior to joining GenerationOne, Mr. Rosen was Vice President of Lincoln Technologies Inc. and of Phase Forward. Previously, he was in charge of KPMG’s Pharmaceutical R&D practice, was a Partner at Computer Sciences Corp HealthCare Division, and held similar positions with Coopers & Lybrand and AGS Computers.
Gloria Griessman
Chief Marketing Officer
Ms. Griessman has more than 20 years experience in market development, branding and strategic marketing with Fortune 500 and privately-held companies. She is widely recognized for her work in establishing new brands and driving aggressive growth for companies in internet media, healthcare and technology. Prior to joining GenerationOne, Ms. Griessman managed marketing efforts for Virtue, a leading social media company. She also served as Vice President of Strategic Marketing for ChoicePoint, where she led market development plans for $250M enterprise and online services division, and as the Vice President of Consumer Marketing for WebMD, where she drove aggressive brand management and online growth resulting in online traffic in excess of 6 million unique monthly visitors. Ms. Griessman also held a number of key marketing roles at Turner Broadcasting, and has also worked with several advertising agencies including McCann-Erickson and Adair-Greene, a leading healthcare agency. Ms. Griessman is a member of the AMA and CMO Club. She received her B.S. in Management from the Georgia Institute of Technology.
Paul Belsky, M.D.
Senior Medical Advisor
Dr. Belsky is focused on seeking and acquiring new technologies for the formation of cutting edge biomedical companies. Dr. Belsky has extensive expertise in the clinical practice of internal medicine and cardiovascular diseases, and was formerly on the clinical academic faculty at Weill College of Medicine, Cornell University. He is a fellow of the American College of Cardiology and the American College of Chest Physicians, is a member of the American College of Physicians, and a Clinical Assistant Professor of Medicine at New York University School of Medicine.
Dr. Belsky served as a scientific advisor to Elusys Therapeutics, Sensatex, and TyrxPharma. He received his M.D. from the University of California at San Francisco, and his AB in Biology from Brown University, where he was elected Phi Beta Kappa.
Board of Directors
Osman Minkara, Chairman
Mr. Osman R. Minkara is the founder and Managing Principal of CIG Corp., a wealth management and advisory services firm located in Metro Detroit.
Since its inception in 1997, Minkara has developed the firm into a substantial niche provider in wealth management and business advisory services for individuals and institutions throughout the United States. Under Minkara’s leadership, the company has developed a wide suite of traditional and alternative wealth management services with focus in healthcare. CIG has a world-renowned Medical Advisory Board and a large majority of clients in the healthcare field.
Minkara serves on multiple boards including Oakland County (Michigan) Economic Roundtable and Wayne University Executive Board and GenerationOne. Minkara has a BS (Finance), Magna Cum Laude, from Wayne State University, an AMP (Advanced Management Programme) from Oxford, and a joint Executive MBA from New York University, London School of Economics and HEC.
Minkara has earned multiple honors in the last few years, his most recent being the 2010 FIVE STAR Wealth Manager, a distinction given to fewer than seven percent of the wealth managers in the Detroit area. Other awards include WSU Emerging Corporate Leader and Detroit Crain’s 40 under 40 (top 40 executives in Michigan under 40 years of age). In addition, he has been interviewed on financial matters by multiple media outlets including CBS and ABC.
John Danaher, M.D.
Dr. Danaher has tremendous expertise in managing e-business growth, translating vision into profitable enterprises, creating strong business infrastructures, and building high performance teams. As a part of the original management team of WebMD, Dr. Danaher was a key contributor to the rapid growth of the innovative healthcare brand and led the development team that launched the $240 million Professional Division. Under his leadership, the company aggressively grew revenues and Internet transactions by delivering administrative and clinical services to healthcare providers and insurers. Additionally, he was a co-integration lead in the merger of WebMD with Healtheon and other acquisitions that form today’s WebMD. Dr. Danaher also served as the Corporate Vice President of Marketing for Foundation Health Systems (now Health Net Inc.), one of the nation’s largest health insurance companies, where he spearheaded the launch of consumer-centric initiatives to improve member retention and satisfaction. As Medical Director of Fourth Generation Medical Management (4G), he executed a major initiative to design and deliver enterprise wide information system solutions that deployed leading-edge disease management offerings.
Dr. Danaher earned his M.D. from Dartmouth Medical School, his MBA from Stanford Business School, and his B.A. from Trinity College. He completed his residency and chief residency in Internal Medicine at Stanford University Medical Center and is board-certified in Internal Medicine.
Jeffrey Wolf
Mr. Wolf is focused on creating, financing, nurturing, and growing new ventures based on breakthrough research and technology. Prior to founding GenerationOne, Mr. Wolf founded and was the Managing Partner of Seed-One Ventures, a firm focused on identifying and acquiring cutting-edge ideas and technologies and the systematic formation and management of early-stage, high-growth companies based on these breakthroughs. Jeff founded and served as Chairman/CEO of several medical technology companies including TyRx Pharma, a company focused on the development of bio-compatible polymers; EluSys Therapeutics, a company focused on the development of a novel technology to remove blood-borne pathogens; Avigen, a San Francisco-based gene therapy company; and Sensatex, a Maryland company focused on the development of novel medical diagnostic systems.
Mr. Wolf received an MBA from Stanford Business School, a J.D. from New York University School of Law and a B.A. with Honors in Economics from the University of Chicago.
James Grotelueschen
Prior to joining GenerationOne, Mr. Grotelueschen was the Vice President of Products at Research in Motion (RIM) where he was responsible for the development and product introduction of the Blackberry product line. Previously, he was Vice President and General Manager of Motorola’s Components Products Division, where he spent 24 years in various capacities in the Cellular Subscriber Sector. Mr. Grotelueschen received his MBA from the University of Chicago and his MSEE and Honors BSEE (Magna Cum Laude) from Marquette University.
Scott Meadow
Mr. Meadow is the Faculty Director of Global Initiatives and since 2000 has held the position of Clinical Professor of Entrepreneurship at the University of Chicago Booth School of Business. Scott Meadow has over 25 years experience as a general partner with four venture capital and private equity firms including William Blair Venture Partners, The Frontenac Company, The Sprout Group and most recently with the Edgewater Funds, where he remains a Senior Advisor. Over the course of his career, Scott has approved hundreds of equity financings, been active in fund-raising and has personally led, originated or created more than sixty investments including two dozen healthcare services companies. Mr. Meadow has been recognized four times by Venture One as one of the outstanding healthcare investors in the industry. He was designated by Business Week’s “Guide to the Best Business Schools” as one of the outstanding entrepreneurial professors in the country. Professor Meadow has taught 5000 students at Chicago Booth, in Entrepreneurial Finance and Private Equity, Commercializing Innovation (which he created) and the New Venture Challenge.
Professor Meadow earned his A.B. Magna Cum Laude from Harvard College and his M.B.A. from Harvard Business School.